The license agreement is transformative but speculative — QUCY is pivoting from pharmaceuticals to drone/cyber tech, diluting existing holders by ~37% and committing $5M cash. The entire deal is cancelable by QUCY if conditions precedent (due diligence, USPTO corrections) aren't met within 90 days. Monitor for satisfaction of conditions precedent and disclosure of the patent schedules (Schedule 1) to assess the IP value. The cross-filing with the CFO consulting agreement (May 4) suggests management restructuring ahead of this pivot. The stock may rally on the narrative shift but faces significant dilution overhang.
Price Chart
Executive Summary
Quantum Cyber N.V. (QUCY) announced three major items on May 12, 2026: (1) a definitive Intellectual Property License Agreement with BP United Inc. to acquire an exclusive, worldwide, perpetual license to technology applicable to drones and cyber technology for $5 million cash + 20 million shares of QUCY restricted stock; (2) an Advisory Agreement paying Alexander Gurevich (BP United's CEO) 5 million restricted shares for advisory services; and (3) the appointment of Peter O'Rourke as a director. The license consideration is contingent on conditions precedent, including QUCY's due diligence satisfaction and corrective USPTO filings. Concurrently, the company entered into a Consulting Agreement with William Caragol as CFO on May 4, 2026, paying $20,000/month. The massive potential dilution (up to ~37% of current shares if all issued) combined with a $5M cash obligation at a $43M market cap represents a transformative but highly dilutive and risky pivot into the drone/cyber tech space.
Key Financial Metrics
Key Facts
- QUCY licensed exclusive, perpetual, worldwide IP (drones, cyber tech) from BP United Inc. for $5M cash + 20M restricted QUCY shares (6-mo lock-up, 5% volume restriction).
- Total potential new shares: 20M to BP United + 5M to Alexander Gurevich (advisor) = 25M shares, issued at $0.40/share reference price — value ~$10M.
- Issuance of 25M shares would increase QUCY's outstanding share count by ~37% vs. current, based on $0.40/sh reference price.
- License is contingent on conditions precedent including QUCY's due diligence satisfaction and corrective USPTO filings within 90 days; QUCY can terminate with no obligation if unmet.
- Licensor BP United warrants the technology is 'ready for commercialization' as of the effective date.
- William Caragol appointed CFO under a consulting agreement on May 4, 2026, at $20,000/month through August 31, 2026.
- Peter O'Rourke appointed to the board effective May 13, 2026, filling a vacancy.
- Market cap is $43M; $5M cash consideration represents ~12% of market cap in cash, plus ~$10M in stock (at reference price) = total deal value ~$15M (35% of market cap).
Financial Impact
Total upfront consideration of $5M cash + 20M shares to BP United and 5M shares to Alexander Gurevich, valued at approximately $15M at $0.40 reference price. This represents ~35% of QUCY's $43M market cap. The $5M cash portion alone represents ~12% of market cap. Combined with prior 8-K's CFO consulting commitment ($20k/month ongoing), the cash burn rate has increased.
Risk Factors
- Potential ~37% dilution from 25M new shares, exacerbating existing shareholder dilution if the stock price is below $0.40.
- $5M cash outlay is significant for a $43M market cap company; elevated cash burn risk.
- License is contingent on due diligence and USPTO corrective filings — if not completed within 90 days, the deal fails and the pivot stalls.
- The licensor (BP United) is a small Delaware corp; CEO Alexander Gurevich is also the paid advisor — potential conflicts of interest.
- Industry pivot from pharma to drones/cyber is outside QUCY's historical business; execution risk is high.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-058427 |
| Document: ea029123601ex10-1.htm | 0001213900-26-058427 |
| Document: ea0291236-8k_quantum.htm | 0001213900-26-058427 |
| Document: 0001213900-26-058427-index-headers.html | 0001213900-26-058427 |
| Document: 0001213900-26-058427-index.html | 0001213900-26-058427 |
| Document: 0001213900-26-058427.txt | 0001213900-26-058427 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | Press Release | $1.03 | awaiting T+20 | — | $0.9050 (−12.14%) |
Oct 16, 2026 10d ago | 8-K | $1.07 | awaiting T+20 | — | $0.9050 (−15.42%) |
Oct 9, 2026 17d ago | 8-K | $1.03 | awaiting T+20 | — | $0.9050 (−12.14%) |
Oct 9, 2026 17d ago | 424B5 | $1.03 | awaiting T+20 | — | $0.9050 (+12.14%) |
Sep 28, 2026 29d ago | Press Release | $1.36 $0.8515 | ▼ −37.39% | ▼ −37.36% | $0.9050 (−33.46%) |
Sep 25, 2026 4w ago | 8-K | $1.37 $1.01 | ▼ −26.28% | ▼ −24.80% | $0.9050 (−33.94%) |
Sep 25, 2026 4w ago | Press Release | $1.37 $1.01 | ▼ −26.28% | ▼ −24.80% | $0.9050 (−33.94%) |
Aug 13, 2026 10w ago | Press Release | $1.42 $1.34 | ▼ −5.63% | ▼ −3.89% | $0.9050 (−36.27%) |
Jul 24, 2026 13w ago | 8-K | $1.08 $1.30 | ▲ +20.37% | ▲ +16.74% | $0.9050 (−16.20%) |
Jul 16, 2026 14w ago | Press Release | $1.19 | awaiting T+20 | — | $0.9050 (−23.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers